An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

Study Identifier
P23-435
CT.gov Identifier
NCT05959070
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Dermatology - Psoriasis (PsO)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Confirmed diagnosis of moderate to severe chronic plaque-type psoriasis diagnosed by a dermatologist and presence of moderate to severe psoriasis symptoms according to physician's clinical judgment at the time of recruitment. * Participants initiating RZB treatment for psoriasis as per local label. Physician's decision for treatment with risankizumab must have been reached prior to and independently of recruitment in the study. * Participants able to understand and communicate with the investigator and comply with the requirements of the study. * Willingness and ability to comply with all study requirements.
    Exclusion Criteria:
    \- Current or recent (within the last 30 days) participation in an interventional clinical trial.

    Protocol Summary

    The IMMagine study aims to validate the newly developed CLCI instrument (DermCLCI-p) in moderate to severe psoriasis (PsO) patients, who will be started on Risankizumb (RZB) treatment and will be enrolled into the validation study up to 28 weeks. The treatment decision for RZB must be made independent of this study enrollment.

    Study Locations

    Location
    Status
    Location
    Universite Libre de Bruxelles - Hopital Erasme /ID# 252456
    Anderlecht, Brussels Capital, Belgium, 1070
    Status
    Not applicable
    Location
    Cliniques Universitaires UCL Saint-Luc /ID# 253234
    Brussels, Brussels Capital, Belgium, 1200
    Status
    Not applicable
    Location
    UZ Gent /ID# 252458
    Ghent, Oost-Vlaanderen, Belgium, 9000
    Status
    Not applicable
    Location
    Dermatologie Maldegem /ID# 252454
    Maldegem, Oost-Vlaanderen, Belgium, 9990
    Status
    Not applicable
    Location
    Universitair Ziekenhuis Leuven /ID# 252457
    Leuven, Vlaams-Brabant, Belgium, 3000
    Status
    Not applicable
    Location
    Wiseman Dermatology Research /ID# 255883
    Winnipeg, Manitoba, Canada, R3M 3Z4
    Status
    Not applicable
    Showing {first} - {last} of {total} Results